Clinical Trials Directory

Trials / Completed

CompletedNCT00846274

Phase1 Syudy to Evaluate the Safety and PK/PD of Human Antithrombin III

Single-Dose, Open Label, Randomized Comparative Clinical Trial to Evaluate the Tolerability, Safety and PK/PD of Human ATIII Products, "SKATIII Injection" and"ATIII Injection" in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
SK Chemicals Co., Ltd. · Industry
Sex
Male
Age
19 Years – 40 Years
Healthy volunteers
Accepted

Summary

To evaluate the PK/PD of single injected human ATIII Products, SKATIII and ATIII, phase1 study in healthy male subjects was designed

Conditions

Interventions

TypeNameDescription
BIOLOGICALSK Antithrombin III

Timeline

Start date
2008-10-01
Primary completion
2008-12-01
Completion
2008-12-01
First posted
2009-02-18
Last updated
2009-02-18

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00846274. Inclusion in this directory is not an endorsement.